Literature DB >> 29641226

The impact of contrast-enhanced spectral mammogram (CESM) and three-dimensional breast ultrasound (3DUS) on the characterization of the disease extend in cancer patients.

Maha Hussien Helal1, Sahar Mahmoud Mansour2, Lamia Adel Salaleldin2, Basma Mohamed Alkalaawy2, Dorria Saleh Salem2, Nadia Mahmoud Mokhtar.   

Abstract

OBJECTIVE: The main importance of imaging breast cancer is to guide conservative surgeries. In this study, we evaluated the role of contrast-enhanced spectral mammogram (CESM) in correlation with three-dimensional (3D) breast ultrasound in characterizing the extension of the intramammary cancer in view of the: (i) the size of the main tumor, (ii) the multiplicity of the breast cancer, and (iii) the peri-tumoral stromal involvement (i.e. free or intraductal extension of the cancer).
METHODS: The study is a prospective analysis that included 300 breast masses proved to be malignant. The masses were evaluated for their size, multiplicity and surrounding stromal involvement. Contrast-based mammography performed with low (22-33 kVp) and high (44-49 kVp) energy exposures that were taken after i.v. injection of contrast agent and followed by bilateral 3D breast ultrasound. Operative data were the gold standard reference.
RESULTS: There was no significant difference between the sizes of the included cancers as measured by CESM and 3D ultrasound and that measured at the pathological analysis. CESM showed higher accuracy (32.7%, n = 98) than 3D ultrasound (24.7%, n = 74) in the size agreement within 5% range. CESM was the most accurate modality (94%, n = 282) in detecting tumor multiplicity, followed by traditional sonomammogram (88%, n = 264), then 3D breast ultrasound (84%, n = 252). Intraductal extension of the breast cancer was best evaluated by the 3D ultrasound with an accuracy value of 98% (n = 294) compared to only 60% (n = 180) by CESM.
CONCLUSION: CESM is a recommended investigation in breast cancer to increase the accuracy of size measurement and the detection of multiple tumors. The addition of 3D ultrasound can enhance the detection of intraductal extension. Advances in knowledge: Choice of conservative breast surgery vs mastectomy is still a debate. We used an advanced, contrast-based, application of the mammogram: CESM and a non-invasive 3D breast ultrasound in the assessment of the local extension of the breast cancer regarding size, perifocal stromal infiltration and multiplicity to guide the selection of proper management in proved cases of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29641226      PMCID: PMC6221789          DOI: 10.1259/bjr.20170977

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  20 in total

1.  Staging of breast cancer and the advanced applications of digital mammogram: what the physician needs to know?

Authors:  Maha H Helal; Sahar M Mansour; Mai Zaglol; Lamia A Salaleldin; Omniya M Nada; Marwa A Haggag
Journal:  Br J Radiol       Date:  2017-02-22       Impact factor: 3.039

Review 2.  Contrast-enhanced dual-energy mammography: a promising new imaging tool in breast cancer detection.

Authors:  Ulrich Lalji; Marc Lobbes
Journal:  Womens Health (Lond)       Date:  2014-05

3.  Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.

Authors:  E M Fallenberg; C Dromain; F Diekmann; F Engelken; M Krohn; J M Singh; B Ingold-Heppner; K J Winzer; U Bick; D M Renz
Journal:  Eur Radiol       Date:  2013-09-19       Impact factor: 5.315

4.  Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma.

Authors:  Maxine S Jochelson; D David Dershaw; Janice S Sung; Alexandra S Heerdt; Cynthia Thornton; Chaya S Moskowitz; Jessica Ferrara; Elizabeth A Morris
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

Review 5.  How to optimize breast ultrasound.

Authors:  Alexandra Athanasiou; Anne Tardivon; Lilliane Ollivier; Fabienne Thibault; Carl El Khoury; Sylvia Neuenschwander
Journal:  Eur J Radiol       Date:  2008-09-24       Impact factor: 3.528

6.  Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements.

Authors:  Bobbi Pritt; Takamaru Ashikaga; Robert G Oppenheimer; Donald L Weaver
Journal:  Mod Pathol       Date:  2004-08       Impact factor: 7.842

7.  Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems.

Authors:  T Ohtake; R Abe; I Kimijima; T Fukushima; A Tsuchiya; K Hoshi; H Wakasa
Journal:  Cancer       Date:  1995-07-01       Impact factor: 6.860

Review 8.  Molecular characterisation of the tumour microenvironment in breast cancer.

Authors:  Min Hu; Kornelia Polyak
Journal:  Eur J Cancer       Date:  2008-11-19       Impact factor: 9.162

9.  Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer.

Authors:  Ines V Gruber; Miriam Rueckert; Karl O Kagan; Annette Staebler; Katja C Siegmann; Andreas Hartkopf; Diethelm Wallwiener; Markus Hahn
Journal:  BMC Cancer       Date:  2013-07-05       Impact factor: 4.430

10.  Contrast-enhanced spectral mammography: comparison with conventional mammography and histopathology in 152 women.

Authors:  Elzbieta Luczyńska; Sylwia Heinze-Paluchowska; Sonia Dyczek; Pawel Blecharz; Janusz Rys; Marian Reinfuss
Journal:  Korean J Radiol       Date:  2014-11-07       Impact factor: 3.500

View more
  2 in total

Review 1.  A review on methods for diagnosis of breast cancer cells and tissues.

Authors:  Ziyu He; Zhu Chen; Miduo Tan; Sauli Elingarami; Yuan Liu; Taotao Li; Yan Deng; Nongyue He; Song Li; Juan Fu; Wen Li
Journal:  Cell Prolif       Date:  2020-06-12       Impact factor: 6.831

2.  Diagnostic value of the enhancement intensity and enhancement pattern of CESM to benign and malignant breast lesions.

Authors:  Xiaoxiao Chi; Lei Zhang; Dong Xing; Peiyou Gong; Qianqian Chen; Yongbin Lv
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.